More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings for the federal government.
Category: Regulation and Deregulation of Industry
-
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
-
Trump and Paramount in ‘Advanced’ Talks to Settle ‘60 Minutes’ Suit
The lawsuit has added a layer of complexity to Paramount’s multibillion-dollar merger with Skydance, a Hollywood studio.
-
Trump Steps Up Pressure Campaign on Powell With Handwritten Note
President Trump has repeatedly attacked Jerome H. Powell, chair of the Federal Reserve, for resisting his demands for lower interest rates.
-
Crypto Industry Moves Into the U.S. Housing Market
Americans are finding ways to use digital currencies to help them buy homes, and new companies are forming to help people tap their home’s value to buy Bitcoin.
-
Wall Street’s Regulatory Reins Start Loosening as Fed Proposes New Rule
The central bank is planning to reduce a capital buffer for the country’s largest banks, which critics warn will make the financial system less resilient.
-
Should the Government Stop Subsidizing a Car Feature That ‘Everyone Hates’?
The E.P.A. under Trump is moving to eliminate credits to carmakers for the fuel-saving start-stop function.
-
Second Fed Official Indicates Support for Faster Rate Cuts
Comments from two officials, both appointed by President Trump, suggest a split among policymakers.
-
Tesla Begins Limited Robotaxi Service in Austin
The vehicles will have safety monitors and may not operate in bad weather, making them more restricted than the fully autonomous vehicles promised by Elon Musk.
-
With Few Discount Airlines, Canadian Travelers Face Steeper Fares
A new report by Canada’s Competition Bureau recommends opening more of the country’s domestic airline market to foreign companies to help lower fares.
-
Insurers Pledge to Ease Controversial Prior Approvals for Medical Care
Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.